June 23, 2003

1 Min Read
Alpha-Tocopheryl Succinate May Hold Anti-Cancer Promise

Alpha-Tocopheryl Succinate May Hold Anti-Cancer Promise

DENVER--Alpha-tocopheryl succinate was deemed the mosteffective form of vitamin E in 1982, when it was compared to alpha-tocopherol,alpha-tocopheryl acetate and alpha-tocopheryl nicotinate for inducingdifferentiation, inhibiting proliferation and encouraging apoptosis of cancercells, according to researchers from the University of Colorado Health SciencesCenter. They published a research review of alpha-tocopheryl succinate in theApril issue of the Journal of the American College of Nutrition (22,2:108-17, 2003) (www.jacn.org), noting severalin vitro and animal studies from the last 20 years have confirmed thisobservation. "The most exciting aspect of this alpha-tocopheryl succinateeffect is that it does not affect the proliferation of most normal cells,"the researchers wrote. They added that in spite of promising research in therealm of anti-cancer properties, the value of the specific form of vitamin E hasnot drawn significant attention, and more research is needed for its potentialrole in cancer management. Researchers concluded, "alpha-tocopherylsuccinate alone or in combination with dietary micronutrients can be useful asan adjunct to standard cancer therapy by increasing tumor response and possiblydecreasing some of the toxicities to normal cells."

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like